Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Adaptive immunity and IL‐17A are not involved in the progression of chronic kidney disease after 5/6 nephrectomy in mice

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and Purpose

          The adaptive immune response and IL‐17A contribute to renal damage in several experimental models of renal injury.

          Experimental Approach

          To evaluate the role of the adaptive immune response, 5/6 nephrectomy was performed in wildtype DBA/1J mice and in recombination‐activating gene‐1 (RAG‐1) deficient mice that lack B and T‐cells. To assess the role of IL‐17A, we carried out 5/6 nephrectomy in IL‐17A deficient mice. Flow cytometric analysis, immunohistochemistry and RT‐PCR were used.

          Key Results

          Infiltration of CD3 + T‐cells in the remnant kidney was increased after 5/6 nephrectomy in wildtype mice, along with a robust induction of IL‐17A production in CD4 + T and γδ T‐cells. After 5/6 nephrectomy, wildtype mice developed albuminuria in the nephrotic range over 10 weeks. This was accompanied by severe glomerular sclerosis and tubulointerstitial injury, and as well as renal mRNA expression of markers of inflammation and fibrosis (the chemokine CCL2, plasminogen activator inhibitor‐1; PAI‐1 and neutrophil gelatinase‐associated lipocalin; NGAL). Unexpectedly, RAG‐1 deficient mice and IL‐17A deficient mice developed renal injury, similar to that in wildtype mice. No differences were found for albuminuria, glomerular sclerosis, tubulointerstitial injury and mRNA expression of CCL2, PAI‐1 and NGAL. Mortality did not differ between the three groups.

          Conclusions and Implications

          Numbers of CD3 + T‐cells and IL‐17A + lymphocytes infiltrating the kidney were increased after 5/6 nephrectomy. In contrast to other experimental models of renal injury, genetic deficiency of the adaptive immune system or of IL‐17A did not attenuate induction or progression of chronic kidney disease after 5/6 nephrectomy.

          Linked Articles

          This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc

          Related collections

          Author and article information

          Contributors
          wenzel@uke.de
          Journal
          Br J Pharmacol
          Br. J. Pharmacol
          10.1111/(ISSN)1476-5381
          BPH
          British Journal of Pharmacology
          John Wiley and Sons Inc. (Hoboken )
          0007-1188
          1476-5381
          18 December 2018
          June 2019
          : 176
          : 12 , Themed Section: Immune Targets in Hypertension. Guest Editors: Antony Vinh, Grant R. Drummond and Christopher G. Sobey ( doiID: 10.1111/bph.v176.12 )
          : 2002-2014
          Affiliations
          [ 1 ] III. Department of Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany
          [ 2 ] Department of Cellular and Integrative Physiology University Medical Center Hamburg‐Eppendorf Hamburg Germany
          [ 3 ] Department of Immunology University Medical Center Hamburg‐Eppendorf Hamburg Germany
          Author notes
          [*] [* ] Correspondence Ulrich Wenzel, III. Medizinische Klinik, University Hospital Hamburg‐Eppendorf, Martinistr. 52, Hamburg 20246, Germany. E‐mail: wenzel@ 123456uke.de
          [†]

          Alva Rosendahl and Reza Kabiri contributed equally to this work.

          Author information
          http://orcid.org/0000-0002-0116-255X
          Article
          PMC6534810 PMC6534810 6534810 BPH14509 2018-BJP-0255-RPT-G.R2
          10.1111/bph.14509
          6534810
          30270435
          059a7d87-8226-4a3c-8f78-ecce5ce36592
          © 2018 The British Pharmacological Society
          History
          : 07 March 2018
          : 21 August 2018
          : 25 August 2018
          Page count
          Figures: 5, Tables: 3, Pages: 13, Words: 5800
          Funding
          Funded by: German Research Foundation
          Award ID: SFB 1192
          Award ID: We 1688/17‐1
          Categories
          Research Paper
          Themed Section: Research Papers
          Custom metadata
          2.0
          bph14509
          June 2019
          Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.3 mode:remove_FC converted:25.05.2019

          Comments

          Comment on this article